Skip to main content

Table 1 Participant characteristics at EDIC baseline by quartile of women’s initial AMH measurement (n = 390 women)

From: Anti-Müllerian hormone and its relationships with subclinical cardiovascular disease and renal disease in a longitudinal cohort study of women with type 1 diabetes

Range of AMH (ng/dl) Quartile 1 Quartile 2 Quartile 3 Quartile 4 p-value
<0.96 0.96–2.70 2.70–4.61 >4.61
n = 99 n = 97 n = 98 n = 97
Age (years) 40.6 ± 6.2 34.6 ± 6.5 32.6 ± 6.0 31.0 ± 5.6 <0.0001
Diabetes duration (years) 14.4 ± 5.0 13.9 ± 5.2 14.4 ± 5.5 13.8 ± 5.4 0.78
Current smoking (%) 26.6% 20.4% 14.7% 15.1% 0.13
Current oral contraceptive use (%) 9.6% 18.3% 17.9% 11.8% 0.23
Body mass index (kg/m2) 26.8 ± 4.7 25.1 ± 3.8 25.8 ± 3.9 25.7 ± 3.8 0.05
Waist circumference (cm) 80.9 ± 11.2 77.2 ± 7.6 77.4 ± 8.6 78.7 ± 8.8 0.02
Systolic blood pressure (mm Hg) 118.4 ± 13.0 113.2 ± 10.8 112.4 ± 11.2 111.7 ± 12.1 0.0005
Diastolic blood pressure (mm Hg) 73.9 ± 8.9 72.8 ± 9.0 71.5 ± 8.4 72.0 ± 9.9 0.27
Hypertensiona 10.6% 7.5% 10.5% 14.0% 0.57
Total cholesterol (mg/dl) 200.5 ± 37.6 174.4 ± 31.0 179.3 ± 30.7 189.1 ± 33.1 <0.0001
Low-density lipoprotein cholesterol (mg/dl) 123.5 ± 34.8 101.8 ± 26.2 106.1 ± 26.8 113.1 ± 26.7 <0.0001
High-density lipoprotein cholesterol (mg/dl) 59.6 ± 14.5 59.6 ± 13.6 59.7 ± 13.8 59.8 ± 14.7 0.99
Triglycerides (mg/dl) 86.5 ± 45.0 65.1 ± 28.1 66.9 ± 30.5 80.6 ± 43.4 0.0001
Lipid medication use (%) 1.1% 2.2% 0% 0% 0.29
Log albumin excretion ratio (mg/day) 2.3 ± 1.0 2.5 ± 1.1 2.2 ± 1.0 2.6 ± 1.1 0.02
Estimated glomerular filtration rate (mL/min/1.73 m2) 106.2 ± 11.9 114.4 ± 16.2 113.3 ± 12.5 116.7 ± 13.3 <0.0001
  1. aHypertension defined as systolic blood pressure ≥ 140 OR diastolic blood pressure ≥ 90 OR anti-hypertensive medication use
  2. Means ± standard deviations or percentages shown